InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
QUANTI-Luc™: Luciferase Detection Reagent | Intratumoral combination therapy with poly(I:C) and resiquimod synergisticall... | 2021 | J Immunother Cancer | Anfra C. et al. | DOI: 10.1136/jitc-2021-002408 |
THP-1 Lucia Reporter Cells (NF-κB) | Intratumoral combination therapy with poly(I:C) and resiquimod synergisticall... | 2021 | J Immunother Cancer | Anfra C. et al. | DOI: 10.1136/jitc-2021-002408 |
Poly(I:C) LMW | Intrauterine immunizations trigger antigen-specific mucosal and systemic immu... | 2021 | Vaccine | Choudhary P. et al. | DOI: 10.1016/j.vaccine.2021.08.080 |
IL-1α & IL-1β Reporter HEK 293 Cells | Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients wit... | 2021 | Cell Discov. | Xue L. et al. | DOI: 10.1038/s41421-021-00299-6 |
IL-6 Reporter HEK 293 Cells | Chimeric antigen receptor T cells self-neutralizing IL6 storm in patients wit... | 2021 | Cell Discov. | Xue L. et al. | DOI: 10.1038/s41421-021-00299-6 |
R848 (Resiquimod) | Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develo... | 2021 | Front Immunol. | Szumilas N. et al. | DOI: 10.3389/fimmu.2021.698420 |
ODN 1585 - TLR9 ligand | Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develo... | 2021 | Front Immunol. | Szumilas N. et al. | DOI: 10.3389/fimmu.2021.698420 |
3'3'-cGAMP | Siglec-H-Deficient Mice Show Enhanced Type I IFN Responses, but Do Not Develo... | 2021 | Front Immunol. | Szumilas N. et al. | DOI: 10.3389/fimmu.2021.698420 |
ODN 2006 (ODN 7909) | Breast cancer-derived DAMPs enhance cell invasion and metastasis, while nucle... | 2021 | Mol Ther Nucleic Acids | Eteshola E.O.U. et al. | DOI: 10.1016/j.omtn.2021.06.016 |
Human TLR9 Reporter HEK293 Cells (NF-κB) | Breast cancer-derived DAMPs enhance cell invasion and metastasis, while nucle... | 2021 | Mol Ther Nucleic Acids | Eteshola E.O.U. et al. | DOI: 10.1016/j.omtn.2021.06.016 |
ODN TTAGGG (A151) | Breast cancer-derived DAMPs enhance cell invasion and metastasis, while nucle... | 2021 | Mol Ther Nucleic Acids | Eteshola E.O.U. et al. | DOI: 10.1016/j.omtn.2021.06.016 |
CPPD Crystals | Polydatin Prevents Calcium Pyrophosphate Crystal-Induced Arthritis in Mice. | 2021 | Nutrients | Oliviero F. et al. | DOI: 10.3390/nu13030929 |
CPPD Crystals | Chondrocytes From Osteoarthritic and Chondrocalcinosis Cartilage Represent Di... | 2021 | Front Cell Dev Biol. | Meyer F. et al. | DOI: 10.3389/fcell.2021.622287 |
Primocin® | Host phospholipid peroxidation fuels ExoU-dependent cell necrosis and support... | 2021 | PLoS Pathog | Bagayoko S. et al. | DOI: 10.1371/journal.ppat.1009927 |
Human TLR5 Reporter HEK293 Cells (NF-κB) | Deimmunization of flagellin for repeated administration as a vaccine adjuvant. | 2021 | NPJ Vaccines | Khim K. et al. | DOI: 10.1038/s41541-021-00379-4 |
HEK-Blue™ Detection | Deimmunization of flagellin for repeated administration as a vaccine adjuvant. | 2021 | NPJ Vaccines | Khim K. et al. | DOI: 10.1038/s41541-021-00379-4 |
Peptide M / Agarose | IgA anti-citrullinated protein antibodies (IgA ACPA) are associated with flar... | 2021 | Rheumatology (Oxford) | Sokolova M.V. et al. | DOI: 10.1093/rheumatology/keab585 |
Anti-hTLR2 Detection and Neutralizing mAb | Phenol-soluble modulins α are major virulence factors of Staphylococcus aureu... | 2021 | Virulence | Damour A. et al. | DOI: 10.1080/21505594.2021.1975909 |
Poly(I:C) HMW | KAP1-Mediated Epigenetic Suppression in Anti-RNA Viral Responses by Direct Ta... | 2021 | J Immunol. | Li Q. et al. | DOI: 10.4049/jimmunol.2100342 |
Poly(I:C) LMW | KAP1-Mediated Epigenetic Suppression in Anti-RNA Viral Responses by Direct Ta... | 2021 | J Immunol. | Li Q. et al. | DOI: 10.4049/jimmunol.2100342 |